NOVEL PEPTIDE HAVING 4 LINKED CTL EPITOPES

• 收藏
• 分享

专利权人:

TAIHO PHARMACEUTICAL CO.; LTD.

发明人:

FUKAYA SATOSHI,OSADA TOSHIHIRO,WADA HIROSHI

申请号：

PH12016500742

公开号：

PH12016500742A1

申请日:

2016.04.20

申请国别(地区):

PH

年份:

2016

代理人:

摘要：

Provided is a cancer antigen peptide which it is possible to administer as a cancer peptide vaccine to a wide range of cancer patients, without the need for HLA testing, and with no limitation to patients having a specific HLA type. This four CTL epitope-joined peptide is obtained by joining, via linkers, of four CTL epitope peptides selected from a group of CTL epitope peptides derived from a tumor antigen molecule, and which have been reported to have CTL inducibility.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/